JPMorgan Chase & Co’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,015
| Closed | -$2K | – | 6051 |
|
|
2021
Q3 | $2K | Sell |
1,015
-4,071
| -80% | -$8.02K | ﹤0.01% | 5407 |
|
|
2021
Q2 | $14K | Buy |
+5,086
| New | +$14K | ﹤0.01% | 5175 |
|
|
2020
Q3 | – | Sell |
-9,329
| Closed | -$26K | – | 5110 |
|
|
2020
Q2 | $26K | Buy |
9,329
+3,920
| +72% | +$10.9K | ﹤0.01% | 4374 |
|
|
2020
Q1 | $13K | Buy |
5,409
+4,695
| +658% | +$11.3K | ﹤0.01% | 4427 |
|
|
2019
Q4 | $4K | Buy |
+714
| New | +$4K | ﹤0.01% | 4606 |
|
|
2019
Q1 | – | Sell |
-1,578
| Closed | -$13K | – | 5035 |
|
|
2018
Q4 | $13K | Sell |
1,578
-779
| -33% | -$6.42K | ﹤0.01% | 4577 |
|
|
2018
Q3 | $46K | Buy |
+2,357
| New | +$46K | ﹤0.01% | 4388 |
|
|
2018
Q2 | – | Sell |
-22,903
| Closed | -$244K | – | 4883 |
|
|
2018
Q1 | $244K | Buy |
22,903
+22,028
| +2,517% | +$235K | ﹤0.01% | 3653 |
|
|
2017
Q4 | $37K | Sell |
875
-64,910
| -99% | -$2.74M | ﹤0.01% | 4224 |
|
|
2017
Q3 | $3.55M | Sell |
65,785
-49,671
| -43% | -$2.68M | ﹤0.01% | 2360 |
|
|
2017
Q2 | $21.4M | Buy |
115,456
+54,328
| +89% | +$10.1M | ﹤0.01% | 1259 |
|
|
2017
Q1 | $7.31M | Buy |
61,128
+2,391
| +4% | +$286K | ﹤0.01% | 1869 |
|
|
2016
Q4 | $5.84M | Sell |
58,737
-1,353
| -2% | -$134K | ﹤0.01% | 2030 |
|
|
2016
Q3 | $6.73M | Sell |
60,090
-49,241
| -45% | -$5.51M | ﹤0.01% | 1816 |
|
|
2016
Q2 | $11.2M | Sell |
109,331
-2,456
| -2% | -$252K | ﹤0.01% | 1567 |
|
|
2016
Q1 | $10.3M | Sell |
111,787
-943
| -0.8% | -$86.6K | ﹤0.01% | 1581 |
|
|
2015
Q4 | $16.3M | Buy |
112,730
+44,425
| +65% | +$6.41M | ﹤0.01% | 1321 |
|
|
2015
Q3 | $7.06M | Buy |
68,305
+15,940
| +30% | +$1.65M | ﹤0.01% | 1775 |
|
|
2015
Q2 | $8.54M | Buy |
+52,365
| New | +$8.54M | ﹤0.01% | 1786 |
|